Suppr超能文献

二氮嗪预处理上调成年大鼠心肌细胞窦房结中的HCN4通道

Pharmacological Preconditioning with Diazoxide Upregulates HCN4 Channels in the Sinoatrial Node of Adult Rat Cardiomyocytes.

作者信息

Orea Wilibaldo, Carrillo Elba D, Hernández Ascención, Moreno Rubén, García María C, Sánchez Jorge A

机构信息

Department of Pharmacology, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City 07360, Mexico.

出版信息

Int J Mol Sci. 2025 Jun 24;26(13):6062. doi: 10.3390/ijms26136062.

Abstract

Cardioprotection against ischemia is achieved using openers of mitochondrial ATP-sensitive K (mitoKATP) channels such as diazoxide (DZX), leading to pharmacological preconditioning (PPC). We previously reported that PPC decreases the abundance of ventricular Cav1.2 channels, but PPC's effects on other channels remain largely unexplored. In this study, we hypothesized that DZX regulates the expression of hyperpolarization-activated cyclic nucleotide potassium channel 4 (HCN4) channels in sinoatrial node cells (SANCs), the specialized cardiomyocytes that generate the heartbeat. DZX increased the heart rate in intact adult rats. Patch-clamp experiments revealed an increase in the magnitude of ionic currents through HCN4 channels, which was abolished by the reactive oxygen species (ROS) scavenger N-acetylcysteine (NAC) and the selective mitoKATP channel inhibitor 5-hydroxydecanoate (5-HD). Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and Western blot assays showed that DZX increased HCN4 channel expression at the mRNA and protein levels. Immunofluorescence analyses revealed that PPC increased HCN4 fluorescence, which was abolished by NAC. DZX increased nuclear translocation of c-Fos and decreased protein abundance of RE1 silencing transcription factor (REST)/neuron-restrictive silencer factor (NRSF), suggesting the involvement of these factors. Our results suggest that PPC increases the heart rate by upregulating HCN4 channel expression through a mechanism involving c-Fos, REST, and ROS.

摘要

使用线粒体ATP敏感性钾通道(mitoKATP)开放剂(如二氮嗪(DZX))可实现对缺血的心脏保护,从而导致药物预处理(PPC)。我们之前报道过,PPC会降低心室Cav1.2通道的丰度,但PPC对其他通道的影响在很大程度上仍未得到探索。在本研究中,我们假设DZX调节窦房结细胞(SANC)中超极化激活的环核苷酸钾通道4(HCN4)的表达,SANC是产生心跳的特殊心肌细胞。DZX可提高成年完整大鼠的心率。膜片钳实验显示,通过HCN4通道的离子电流幅度增加,活性氧(ROS)清除剂N-乙酰半胱氨酸(NAC)和选择性mitoKATP通道抑制剂5-羟基癸酸酯(5-HD)可消除这种增加。定量逆转录聚合酶链反应(qRT-PCR)和蛋白质免疫印迹分析表明,DZX在mRNA和蛋白质水平上增加了HCN4通道的表达。免疫荧光分析显示,PPC增加了HCN4荧光,而NAC可消除这种荧光。DZX增加了c-Fos的核转位,并降低了RE1沉默转录因子(REST)/神经元限制性沉默因子(NRSF)的蛋白质丰度,提示这些因子参与其中。我们的结果表明,PPC通过一种涉及c-Fos、REST和ROS的机制上调HCN4通道表达,从而提高心率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b9/12249526/db65759a5cb2/ijms-26-06062-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验